Mini Oral - Genitourinary tumours, prostate
Invited Discussant 615MO and 616MO
Date
18 Sep 2020Session
Mini Oral - Genitourinary tumours, prostatePresenters
Andrea AlimontiAuthors
A. AlimontiAuthor affiliations
- Molecular Oncology Department, EOC - Ospedale Regionale Bellinzona e Valli - Istituto Oncologico della Svizzera Italiana (IOSI), 6500 - Bellinzona/CH
Resources
Resources from the same session
612MO - Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
Presenter: Rebeca Lozano Mejorada
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
614MO - Cabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects
Presenter: Mihaela Aldea
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
LBA22 - Imaging based PCa screening among BRCA mutation carriers: Results from the first round of screening
Presenter: David Margel
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
615MO - Phase Ib/II study of VERU-111, novel, oral tubulin inhibitor, in men with metastatic castration resistant prostate cancer (mCRPC) who failed an androgen blocking agent
Presenter: Mark Markowski
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
616MO - Efficacy of BN-brachyury (BNVax) + bintrafusp alfa (BA) + N-803 in castration-resistant prostate cancer (CRPC): Results from a preliminary analysis of the Quick Efficacy Seeking Trial (QuEST1)
Presenter: Jason Redman
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
617MO - Repurposing metformin as an anticancer drug: Preliminary results of randomized controlled trial in advanced prostate cancer (MANSMED)
Presenter: Reham Alghandour
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
618MO - Local therapy to the primary tumour for newly diagnosed, oligo-metastatic prostate cancer: A prospective randomized, phase II, open-label trial
Presenter: Bo Dai
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Open & welcome
Presenter: Eleni Efstathiou
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Webcast
Invited Discussant 612MO, 614MO and LBA22
Presenter: Eleni Efstathiou
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Webcast
Invited Discussant 617MO and 618MO
Presenter: Noel Clarke
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.